Business Daily Media

Business Marketing

APOLLOMICS, INC ANNOUNCES SUCCESSFUL ENROLLMENT OF FIRST PATIENT INTO PHASE 1 CLINICAL TRIAL OF APL-106 (UPROLESELAN INJECTION) IN CHINA

  • Written by ACN Newswire - Press Releases

APOLLOMICS, INC ANNOUNCES SUCCESSFUL ENROLLMENT OF FIRST PATIENT INTO PHASE 1 CLINICAL TRIAL OF APL-106 (UPROLESELAN INJECTION) IN CHINA

FOSTER CITY, Calif. and HANGZHOU, ZHEJIANG, CHINA, Mar 4, 2021 - (ACN Newswire) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the first patient has been successfully enrolled into a Phase 1 clinical trial of APL-106

Read more //?#

Popular

Things you don’t have to do yourself as a business owner

So many people in small businesses feel that doing things for themselves is the way to go. “It costs me nothing,” is usually the justification for the decision, and on some levels that is very true. The reality though is that it c...

Overcoming inflation: Creating a pricing strategy for your restaurant's menu

As inflation continues to hit business budgets across Australia, restaurants are grappling with escalating operating costs by raising menu prices. According to Australian Bureau of Statistics data released in January, the cost o...

Prime Minister's Remarks, Business Reception - Queenstown, New Zealand

Thank you very much, Prime Minister. I'm going to follow the same practice that you have. Jacinda, it’s wonderful to be with you and Clarke. Jenny and I are very pleased to be back here in Queenstown. Tena koutou, tena koutou...

Virtual Office
Tomorrow Business Growth